Why Are People Filing Wegovy Lawsuits?
People are filing lawsuits against Wegovy after developing serious complications while taking the drug. These medical product liability lawsuits seek accountability from Wegovy’s manufacturer, Novo Nordisk, for injuries that patients claim they were never warned about.
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist approved to help certain adults and teens with obesity or overweight lose weight.
Wegovy lawsuits allege that Novo Nordisk:
- Designed a drug with defects that made it unsafe
- Failed to warn about serious Wegovy side effects like vision loss
- Knew or should have known about the dangers
There are also 2 federal multidistrict litigations (MDLs) against companies that made Wegovy and other GLP-1 drugs in Pennsylvania. One handles gastrointestinal (GI) injuries, and the other handles an eye condition called non-arteritic anterior ischemic optic neuropathy (NAION).
However, those aren’t the only unexpected complications allegedly caused by the weight loss drug. If Wegovy affected your health in ways you never expected, our team may be able to help.
See if you qualify for a Wegovy lawsuit now.
What Are the Side Effects of Wegovy?
The most common Wegovy side effects affect the digestive system. In clinical trials, 30% of adults taking the Wegovy shot had diarrhea, and 44% had nausea.
However, Wegovy claims cite more serious side effects like:
- Gastroparesis (stomach paralysis)
- Ileus (stalled bowels)
- Intestinal obstruction
- NAION (vision loss)
Other serious risks have also been studied. A 2023 JAMA study found that people taking GLP-1 drugs for weight loss had about 9 times the risk of pancreatitis compared with people taking a different weight loss medication.
No one should have to live with lasting harm from a drug they trusted to improve their health.
How Do You Qualify for a Wegovy Lawsuit?
Not everyone who took Wegovy and later got sick will qualify for a lawsuit. However, don’t rule yourself out. We can help you understand whether your experience may support a claim.
You may qualify for a lawsuit against Wegovy if you:
- Developed NAION, gastroparesis, or another serious injury after starting Wegovy
- Needed medical treatment or hospitalization for your injury
- Took Wegovy as prescribed by a medical professional
- Weren’t aware of the full risks before starting the drug
Your medical records could play a big role in your Wegovy lawsuit, and you don’t have to collect the evidence alone. One of our partner weight loss drug attorneys can strengthen your claim.
Call (877) 640-6101 so we can review your eligibility.
Wegovy Lawsuit Updates and News
Judge Karen S. Marston is handling federal Wegovy claims in the U.S. District Court for the Eastern District of Pennsylvania. Following the latest news can help you understand how these lawsuits move forward and how compensation is divided.
Here are the latest Wegovy lawsuit updates:
- October 1, 2026: Court data showed that there were still 4,025 GI injury cases and 247 NAION cases pending against GLP-1 drugmakers.
- September 22, 2026: News outlets reported that a 66-year-old Georgia nurse practitioner sued Novo Nordisk after losing vision in one eye while taking Wegovy.
- July 2, 2026: The judge overseeing MDL 3163 ordered early discovery, when both sides share evidence, on whether GLP-1 drugs can cause NAION and whether federal law blocks failure-to-warn claims.
- March 16, 2026: The court scheduled a Science Day for June 2, 2026, so both sides could explain the science behind GLP-1 drugs and possible NAION risks.
- December 15, 2025: A federal panel created a separate MDL (3163) for vision loss claims involving Wegovy, Rybelsus®, Trulicity®, and other GLP-1 drugs.
- May 2, 2024: A Wegovy lawsuit was filed involving a Pennsylvania woman who alleged Wegovy left her with stomach cramps and vomiting. It joined other GI injury lawsuits against Wegovy, Ozempic®, Mounjaro®, and similar drugs in MDL 3094.
As of October 2026, both MDLs are still in pretrial stages. It may not be too late to take legal action, so reach out for support if you’ve been harmed by Wegovy side effects and want to file a claim.
Wegovy Lawsuit Settlement Amounts
There have been no Wegovy settlements or verdicts as of October 2026. Both federal MDLs are still moving through pretrial steps.
Future Wegovy settlements may depend on:
- Injury severity
- Long-term effects on daily life
- Lost income
- Medical costs
- Strength of medical records
- Other case-specific factors
Our partner law firm has experience negotiating compensation and seeking verdicts. They’ve recovered $1.6 billion to date for people harmed by dangerous drugs and medical devices.
What Wegovy Lawsuit Compensation May Be Available?
Wegovy compensation may be available to people who took the medication and experienced life-changing adverse effects. A settlement or verdict can make daily life easier to manage.
Serious vision loss or digestive injuries can change routines you once handled without thinking twice. You may struggle to drive, work, read, or care for your family on your own because you weren’t aware of the full risks of taking a weight loss medication like Wegovy.
A Wegovy settlement could help you cover:
- Emotional distress
- Future medical care
- Home or vision accommodations
- Lost wages and earning ability
- Medical bills
- Pain and suffering
- Reduced quality of life
- Other related expenses
Every case is different, so compensation isn’t guaranteed. However, a Wegovy settlement or verdict may ease the financial strain of a serious injury.
How to File a Lawsuit Against Wegovy
If you believe you weren’t properly warned about potential Wegovy side effects before developing a serious condition, you may be able to file a Wegovy lawsuit. Your claim could help you seek accountability and compensation from Novo Nordisk through civil court.
Here’s what the filing process may look like:
- Get a free case review: Talk with our team about your experience with Wegovy to see if you can connect with our partner law firm.
- Gather your records: Your Wegovy attorney will collect your medical and prescription records, along with any other evidence that could strengthen your case.
- File your Wegovy lawsuit: Your lawyer will file your case in the right court before the filing deadline passes.
- Let your lawyer handle the legal process: Your Wegovy lawsuit lawyer can work toward a fair settlement or, if needed, represent you at trial.
Filing a Wegovy claim is a straightforward process with our team. We’ll answer your questions, provide clarity, and help you take the next step if you qualify.
How Long Do You Have to File a Wegovy Lawsuit?
Each state’s statute of limitations sets a deadline for filing a Wegovy lawsuit. The length of time varies by state and type of claim, which is why it’s crucial to work with an experienced Wegovy lawyer who understands the deadline in your case.
Some states give people 2 to 3 years to file medical product liability claims, but others only allow 1 year before Wegovy lawsuits and similar cases are disqualified.
The clock may start on the date of your injury or the date you discovered it was connected to your Wegovy prescription. If you miss your deadline, you may lose your right to seek compensation, so it’s important to act quickly.
Learn about your legal options now.
Get Help Filing a Wegovy Lawsuit
You likely started taking Wegovy to make a positive change for your health. If you developed vision loss, stomach paralysis, or another serious injury instead, you deserve answers.
We can help you work with a Wegovy lawsuit attorney if you’re eligible. They’ll navigate the legal system so you can focus on your recovery.
Get a free case review or call (877) 640-6101 today to learn more about filing a Wegovy lawsuit. You could be eligible for compensation that helps you afford ongoing care.
Wegovy Lawsuit FAQs
Why are people stopping Wegovy?
Many people stop taking Wegovy because of cost or side effects. Among U.S. adults who have ever used a GLP-1 drug, 14% stopped because of cost and 13% stopped because of adverse effects, which may include serious complications like stomach paralysis and vision loss.
If you stopped taking Wegovy after an unexpected symptom developed, you may have legal options. Contact us now to see if you can file a Wegovy lawsuit and access compensation to help pay for treatments and other related expenses.
Are there lawsuits against Wegovy?
Yes, Wegovy is named in federal lawsuits claiming that GLP-1 drugs caused NAION, which can lead to sudden, permanent vision loss. Wegovy lawsuits centered on GI issues are also grouped together in MDL 3094 in the Eastern District of Pennsylvania.
The lawsuits claim that people developed NAION or serious GI conditions after taking Wegovy and that Novo Nordisk failed to adequately warn patients about the risk.
Is there a Wegovy class action lawsuit?
There isn’t a Wegovy class action lawsuit, but the medication is named in 2 federal MDLs. The types of litigation differ slightly.
Class action suits combine identical claims and divide compensation equally. The MDLs combine similar Wegovy lawsuits, but allow each claimant to get individual compensation amounts depending on the evidence provided in each case.
How long do I have to file a Wegovy lawsuit?
Your state’s statute of limitations determines how long you have to file a Wegovy lawsuit. The deadline varies by state and type of claim. Some states give people 2 to 3 years, while others only allow 1 year to file a medical product liability lawsuit.
If you’ve experienced severe Wegovy side effects, you should explore your legal options quickly. Get a free case review now to discuss the best course of action for your case.
Written by: Her Case Matters
At HerCaseMatters, we believe women deserve to be heard — especially when it comes to their health and safety. Too often, harmful drugs, devices, and corporate wrongdoing impact women’s lives without proper warning, support, or accountability. We’re here to change that. We work with trusted legal partners who are deeply experienced in holding powerful companies accountable. But more than that, we’re here to remind women everywhere that their pain is real, their experiences matter, and they deserve justice.
- Cleveland Clinic. (n.d.). Semaglutide injection. Retrieved from: https://my.clevelandclinic.org/health/drugs/23611-semaglutide-injection-weight-management.
- KFF. (November 14, 2025). Poll: 1 in 8 adults say they are currently taking a GLP-1 drug for weight loss, diabetes or another condition, even as half say the drugs are difficult to afford. Retrieved from: https://www.kff.org/public-opinion/poll-1-in-8-adults-say-they-are-currently-taking-a-glp-1-drug-for-weight-loss-diabetes-or-another-condition-even-as-half-say-the-drugs-are-difficult-to-afford/.
- Sodhi, M., Rezaeianzadeh, R., Kezouh, A., & Etminan, M. (October 5, 2023). Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. Retrieved from: https://jamanetwork.com/journals/jama/fullarticle/2810542.
- Sokolove Law. (September 10, 2026). Wegovy Lawsuit. Retrieved from: https://www.sokolovelaw.com/dangerous-drugs/ozempic/wegovy/.
- The Philadelphia Inquirer. (May 2, 2024). Why a legal fight against the manufacturers of Ozempic, Mounjaro, and other diabetes and weight-loss drugs will take place in a Philly courtroom. Retrieved from: https://www.inquirer.com/health/weight-loss-diabetes-drugs-lawsuits-philadelphia-federal-court-glp1-20240502.html.
- Today. (September 22, 2026). Woman details losing vision in 1 eye after taking GLP-1 as hundreds of patients sue drug companies. Retrieved from: https://www.today.com/health/news/vision-loss-ozempic-semaglutide-glp-1-lawsuit-rcna599232.
- U.S. Food and Drug Administration. (n.d.). Wegovy prescribing information. Retrieved from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218316s005lbl.pdf.
- United States District Court, Eastern District of Pennsylvania. (July 2, 2026). In re: Glugagon-like peptide-1 receptor agonists (GLP-1 RAs) non-arteritic anterior ischemic optic neuropathy products liability litigation. Retrieved from: https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/25md3163_cm-ord_12.pdf.
- United States Judicial Panel on Multidistrict Litigation. (Decembver 15, 2025). Transfer order. Retrieved from: https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3163-Transfer_Order-12-25.pdf.
- United States Judicial Panel on Multidistrict Litigation. (October 1, 2026). MDL statistics report – Distribution of pending MDL dockets by actions pending. Retrieved from: https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-October-1-2026.pdf.
